MUC1 and triple-negative breast carcinoma: While our previous studies have demonstrated the regulation of glycolytic metabolism in pancreatic cancer or glutamine metabolism in triple-negative breast cancer, our results from this study shed light on the functional implications of the MUC1 oncoprotein in pancreatic cancer progression through the regulation of polyamine biosynthesis (6, 8).